← Leaderboards
Arianna L Kim
Columbia University Health Sciences
$1,921,261
Attributed
$2,832,511
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $364.5K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,832,511 · 4
By mechanism
R01$1,822,500 · 1
K01$618,300 · 1
R21$230,711 · 1
R03$161,000 · 1
Top collaborators
- David Rinsey Bickers5 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- David Rinsey Bickers$13,811,205
- Jean Gautier$20,960,007
- Mohammad Athar$24,147,707
- Kenneth P Olive$11,212,298
Others in their field
Top investigators on “Keratinocyte”
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Kathleen Janee Green · Northwestern University$26,824,381
- Elaine Fuchs · University Of Chicago$24,033,644
- Gian Paolo Dotto · Massachusetts General Hospital$19,822,465
- Richard L Gallo · University Of California, San Diego$19,668,478
- Pierre Coulombe · Johns Hopkins University$19,316,020
Research focus
KeratinocyteMalignant NeoplasmsTumorCellsIn VivoPathway InteractionsTumor GrowthGerm-Line MutationSignal TransductionMutationBasal Cell CarcinomaMolecularResistanceIn VitroTumor Suppressor ProteinsGrowthReconstitutionPreventionProteinsMouse ModelEpidermisRegulationAutomobile DrivingChromatin
Grant awards (13)
Targeting Tumor-Driven Immune Tolerance to Overcome Resistance to Hedgehog Inhibition$230,711
R21 · FY2025 · CA · contact PI
Molecular Mechanisms Underlying the Prevention of BCC Resistance$364,500
R01 · FY2024 · ES
Molecular Mechanisms Underlying the Prevention of BCC Resistance$364,500
R01 · FY2023 · ES
Molecular Mechanisms Underlying the Prevention of BCC Resistance$364,500
R01 · FY2022 · ES
Molecular Mechanisms Underlying the Prevention of BCC Resistance$364,500
R01 · FY2021 · ES
Molecular Mechanisms Underlying the Prevention of BCC Resistance$364,500
R01 · FY2020 · ES
Chk2 as a target for regulating senescence in skin neoplasia$80,500
R03 · FY2008 · CA · contact PI
Cell cycle regulatory proteins in UVB-skin carcinogenes$123,660
K01 · FY2007 · AR · contact PI
Chk2 as a target for regulating senescence in skin neoplasia$80,500
R03 · FY2007 · CA · contact PI
Cell cycle regulatory proteins in UVB-skin carcinogenes$123,660
K01 · FY2006 · AR · contact PI
Cell cycle regulatory proteins in UVB-skin carcinogenes$123,660
K01 · FY2005 · AR
Cell cycle regulatory proteins in UVB-skin carcinogenes$123,660
K01 · FY2004 · AR
Cell cycle regulatory proteins in UVB-skin carcinogenes$123,660
K01 · FY2003 · AR